Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Inventory Average: 2013-2025

Historic Inventory Average for Ani Pharmaceuticals (ANIP) over the last 12 years, with Sep 2025 value amounting to $142.4 million.

  • Ani Pharmaceuticals' Inventory Average rose 4.13% to $142.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.4 million, marking a year-over-year increase of 4.13%. This contributed to the annual value of $124.0 million for FY2024, which is 14.51% up from last year.
  • Ani Pharmaceuticals' Inventory Average amounted to $142.4 million in Q3 2025, which was up 3.29% from $137.9 million recorded in Q2 2025.
  • Ani Pharmaceuticals' 5-year Inventory Average high stood at $142.4 million for Q4 2024, and its period low was $65.7 million during Q1 2021.
  • Over the past 3 years, Ani Pharmaceuticals' median Inventory Average value was $119.6 million (recorded in 2024), while the average stood at $122.9 million.
  • Data for Ani Pharmaceuticals' Inventory Average shows a peak YoY soared of 46.93% (in 2022) over the last 5 years.
  • Ani Pharmaceuticals' Inventory Average (Quarterly) stood at $78.2 million in 2021, then skyrocketed by 34.75% to $105.3 million in 2022, then rose by 3.37% to $108.9 million in 2023, then skyrocketed by 30.78% to $142.4 million in 2024, then grew by 4.13% to $142.4 million in 2025.
  • Its Inventory Average was $142.4 million in Q3 2025, compared to $137.9 million in Q2 2025 and $137.1 million in Q1 2025.